Journals / Turkish Journal of Obstetrics and Gynecology / 2018 / Cilt: 15 - Sayı: 4

Maternal platelet-to-lymphocyte ratio at delivery can predict poor neonatal outcome in preterm births

Doğumda maternal platelet-lenfosit oranı preterm doğumlarda kötü neonatal sonlanımları öngörebilir

Pages
254–258
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It can predict preterm neonates with poor outcomes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine the role of the platelet-to-lymphocyte ratio (PLR) in predicting poor neonatal outcome among preterm births (PTB).Materials and Methods: The medical records of 439 PTBs and 200 normal pregnancies were reviewed retrospectively using some personal and obstetricdata, as well as complete blood count reports.Results: There were significantly poor neonatal outcomes among PTBs in regard to birth weight, APGAR score, morbidity, and mortality.
📊
Key Findings & Data:There weresignificantly poor outcomes for preterm neonates delivered to mothers with PLR ≥80 at delivery for low APGAR score, respiratory distress syndrome,intraventricular hemorrhage and perinatal death.
💡
Conclusion & Impact:It can predict preterm neonates with poor outcomes.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To determine the role of the platelet-to-lymphocyte ratio (PLR) in predicting poor neonatal outcome among preterm births (PTB).Materials and Methods: The medical records of 439 PTBs and 200 normal pregnancies were reviewed retrospectively using some personal and obstetricdata, as well as complete blood count reports.Results: There were significantly poor neonatal outcomes among PTBs in regard to birth weight, APGAR score, morbidity, and mortality. There weresignificantly poor outcomes for preterm neonates delivered to mothers with PLR ≥80 at delivery for low APGAR score, respiratory distress syndrome,intraventricular hemorrhage and perinatal death. There was a significant negative correlation between maternal PLR at delivery and birth weight, as wellas gestational age of PTB.Conclusion: Maternal PLR at delivery has a significant relationship with neonatal outcomes. It can predict preterm neonates with poor outcomes.

Özet

Amaç: Preterm doğumlar (PTD) arasında kötü neonatal sonlanımları öngörme açısından platelet-lenfosit oranının (PLO) rolünü belirlemektir. Gereç ve Yöntemler: Dört yüz otuz dokuz PTD ve 200 normal gebeliğin tıbbi kayıtları, bazı kişisel ve obstetrik veriler ile tam kan sayımı raporları kullanılarak retrospektif olarak incelendi. Bulgular: PTD’ler arasında; doğum ağırlığı, APGAR skoru, morbidite ve mortalite açısından anlamlı derecede kötü neonatal sonlanımlar vardı. Doğum sırasında PLO ≥80 olan annelerin dünyaya getirdiği preterm yenidoğanlarda, düşük APGAR skoru, respiratuar distres sendromu, intraventiküler kanama ve perinatal ölüm açısından anlamlı kötü sonuçlar elde edildi. Doğum sırasındaki maternal PLO ile doğum ağırlığı ve PTD gestasyonel yaşı arasında anlamlı negatif korelasyon vardı. Sonuç: Doğumdaki maternal PLO’nun neonatal sonlanımlar ile anlamlı bir ilişkisi bulunmaktadır. Bu şekilde kötü sonlanımlı preterm yenidoğanlar öngörülebilir

🔖

Cite This Article

JAFFAR, D. W., RABİE, M. A. F. (2022). Maternal platelet-to-lymphocyte ratio at delivery can predict poor neonatal outcome in preterm births. Turkish Journal of Obstetrics and Gynecology, Cilt: 15 - Sayı: 4, 254–258. https://ajindex.com/articles/613041

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Moore ML. Preterm Birth: A Continuing Challenge. The Journal of Perinatal Education 2002;11:37-40. Lumley J. Defining the problem: the epidemiology of preterm birth. BJOG: An Intern J Obstet Gynaecol 2003;110:3-7. Li N. Platelet–lymphocyte cross-talk. J leukocyte biol 2008;83:1069- 78. Gerdes N, Zhu L, Ersoy M, Hermansson A, Hjemdahl P, Hu H, et al. Platelets regulate CD4+ T-cell differentiation via multiple chemokines in humans. Thrombosis and haemostasis 2011;105:353-62.
  2. Gibson PH, Cuthbertson BH, Croal BL, Rae D, El-Shafei H, Gibson G, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010;105:186-91.
  3. Toprak E, Bozkurt M, Çakmak BD, Özçimen EE, Silahlı M, Yumru AE, et al. Platelet-to-lymphocyte ratio: A new inflammatory marker for the diagnosis of preterm premature rupture of membranes. J Turkish German Gynecol Assoc 2017;18:122. Yavuzcan A, Caglar M, Ustun Y, Dilbaz S, Yidiz E, Ozbilgec S, et al. Mean platelet volume, neutrophil-lymphocyte ratio and plateletlymphocyte ratio in severe preeclampsia. Ginekologia polska 2014;85. Yücel B, Ustun B. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, red cell distribution width and plateletcrit in preeclampsia. Pregnancy Hypertension: An Intern J Women’s Cardiovascular Heal 2017;7:29-32.
  4. Toptas M, Asik H, Kalyoncuoglu M, Can E, Can MM. Are Neutrophil/ Lymphocyte Ratio and Platelet/Lymphocyte Ratio Predictors for Severity of Preeclampsia? J Clin Gynecol Obstet 2016;5:27-31.
  5. Kurtoglu E, Kokcu A, Celik H, Sari S, Tosun M. Platelet indices may be useful in discrimination of benign and malign endometrial lesions, and early and advanced stage endometrial cancer. Asian Pac J Cancer Prev 2015;16:5397-400.
  6. Klement AH, Hadi E, Asali A, Shavit T, Wiser A, Haikin E, et al. Neutrophils to lymphocytes ratio and platelets to lymphocytes ratio in pregnancy: A population study. PloS one 2018;13:e0196706. Roos N, von Xylander SR. Why do maternal and newborn deaths continue to occur? Best Pract Res Clin Obstet Gynaecol 2016;36: 30-44.
  7. Cleary-Goldman J, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock CH, et al. Impact of maternal age on obstetric outcome. Obs Gynecol 2005;105:983-990.
  8. Bateman BT, Mhyre JM, Hernandez-Diaz S, Huybrechts KF, Fischer MA, Creanga AA, et al. Development of a comorbidity index for use in obstetric patients. Obs Gynecol 2013;122:1-18.
  9. Aminu M, Unkels R, Mdegela M, Utz B, Ad